Key result
Walking distance-based multimarker score linked to ~2.4-fold higher 1-year mortality or LVAD risk per point.
Why the study?
Does integrating six-minute walk distance into a simple multimarker score improve prediction of 1-year all-cause mortality or LVAD implantation in patients with HFrEF?
Cohort (n=450)
Does integrating six-minute walk distance into a simple multimarker score improve prediction of 1-year all-cause mortality or LVAD implantation in patients with HFrEF?
Integrating six-minute walk distance with NT-proBNP, LVEF, and systolic blood pressure into a simple score effectively stratifies 1-year risk of mortality or LVAD implantation in advanced HFrEF patients.
Answers are grounded in this paper and cite their sources.
May aid 1-year risk stratification in advanced HFrEF; leaves open need for prospective validation and impact on decisions.
Background Six-minute walk distance (6MWD) is a widely used marker of functional capacity in heart failure, yet its integration with routine clinical variables for bedside risk stratification remains insufficient. Purpose To evaluate whether integrating 6MWD into a simple multimarker score improves prediction of 1-year all-cause mortality or LVAD implantation in patients with HFrEF. Methods We prospectively followed 450 HFrEF patients (mean age 51.9±10.1 years; mean LVEF 25.9±6.6%; median NT-proBNP 1676 [731–3448] ng/L). Heart transplantation recipients were excluded. The primary endpoint was 1-year all-cause mortality or LVAD implantation. A simple score integrated functional capacity (6MWD <415 m, 2 points) with NT-proBNP >1000 ng/L (2 points), LVEF <30% (1 point), and systolic blood pressure <100 mmHg (1 point). Cox regression, Kaplan-Meier and ROC analyses were performed. Results When analysed as a continuous variable, the score showed strong association with the endpoint (HR per 1-point increase 2.40, 95% CI 1.85–3.11). Patients were stratified into low (0–1 points, n=101), intermediate (2–3 points, n=202), and high-risk groups (4–6 points, n=147) with event rates of 0%, 4.95%, and 22.45%, respectively (log-rank p<0.001). Kaplan-Meier curves demonstrated clear stepwise risk separation (Picture 1). The score showed good discrimination (AUC 0.82), indicating that integration of 6MWD improves risk stratification beyond individual markers. Conclusion Integrating functional capacity into a pragmatic multimarker score enables effective short-term risk stratification in HFrEF. Incorporation of 6MWD identifies a very-low-risk group and a markedly high-risk phenotype, supporting its role in bedside decision-making and referral to advanced heart failure therapies.
No takes yet. Share an insight, caveat, or question.
Chudy et al. (2026) conducted a cohort in Advanced heart failure with reduced ejection fraction (HFrEF) (n=450). Multimarker risk score integrating 6MWD (<415 m), NT-proBNP (>1000 ng/L), LVEF (<30%), and SBP (<100 mmHg) vs. Low-risk score group (0–1 points) or per 1-point lower score was evaluated on 1-year all-cause mortality or LVAD implantation (HR 2.40 per 1-point increase, 95% CI 1.85-3.11, p=<0.001). A multimarker score integrating walking distance strongly predicted 1-year mortality or LVAD implantation in HFrEF.
Synapse has enriched 10 related papers. Consider them for comparative context: